APA

Eyck B. M., van der Wilk B. J., Lagarde S. M., Wijnhoven B. P. L., Valkema R., Spaander M. C. W., Nuyttens J. J. M. E., van der Gaast A. & van Lanschot J. J. B. (20190125). Neoadjuvant chemoradiotherapy for resectable oesophageal cancer. : Best practice & research. Clinical gastroenterology.

Chicago

Eyck B M, van der Wilk B J, Lagarde S M, Wijnhoven B P L, Valkema R, Spaander M C W, Nuyttens J J M E, van der Gaast A and van Lanschot J J B. 20190125. Neoadjuvant chemoradiotherapy for resectable oesophageal cancer. : Best practice & research. Clinical gastroenterology.

Harvard

Eyck B. M., van der Wilk B. J., Lagarde S. M., Wijnhoven B. P. L., Valkema R., Spaander M. C. W., Nuyttens J. J. M. E., van der Gaast A. and van Lanschot J. J. B. (20190125). Neoadjuvant chemoradiotherapy for resectable oesophageal cancer. : Best practice & research. Clinical gastroenterology.

MLA

Eyck B M, van der Wilk B J, Lagarde S M, Wijnhoven B P L, Valkema R, Spaander M C W, Nuyttens J J M E, van der Gaast A and van Lanschot J J B. Neoadjuvant chemoradiotherapy for resectable oesophageal cancer. : Best practice & research. Clinical gastroenterology. 20190125.